Methods and compositions for treating human cells
CA 2306355 A1 · Owner: Klatzmann, David · Inventors: Klatzmann, David; Loubiere, Laurence
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to methods and compositions for treating human cells. In particular, the invention relates to the use of an Equine herpes virus type-4 (EHV4) thymidine kinase polypeptide or a nucleic acid coding therefor for the manufacture of a composition to render human cells sensitive to a nucleoside analog in vitro ex vivo or in vivo. The invention can be used in experimental biological, screening or, therapeutical applications.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 19, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 19, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 19, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.